A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements
about
Insight into the diagnosis and management of subclinical genital tuberculosis in women with infertilityThe TB pandemic: an old problem seeking new solutions.Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposureAnalysis of latent tuberculosis and mycobacterium avium infection data using mixture models.Prevalence and predictors of tuberculin skin positivity in Hellenic Army recruitsHeparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia.Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin testEvidence-based tuberculosis diagnosis.Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area.Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam.Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South AfricaPerformance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated populationJoint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysisThe tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts.Infection control and the burden of tuberculosis infection and disease in health care workers in china: a cross-sectional study.Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran.Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contactsCommunity-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin testThe clinical utility of tuberculin skin test and interferon-γ release assay in the diagnosis of active tuberculosis among young adults: a prospective observational studyKinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shantytown, Peru.Tuberculosis skin testing, anergy and protein malnutrition in Peru.Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workersPoor performance of serological tests in the diagnosis of pulmonary tuberculosis: evidence from a contact tracing field study.Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birthRecent advances in testing for latent TB.Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area.New approaches in the diagnosis and treatment of latent tuberculosis infectionDetermining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine.Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction.The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South KoreaLow agreement between the T-SPOT®.TB assay and the tuberculin skin test among college students in China.Tuberculin skin test and Quantiferon test agreement and influencing factors in tuberculosis screening of healthcare workers: a systematic review and meta-analysis.Enhanced patient serum immunoreactivity to recombinant Mycobacterium tuberculosis CFP32 produced in the yeast Pichia pastoris compared to Escherichia coli and its potential for serodiagnosis of tuberculosis.
P2860
Q28075513-0D1B1D07-9138-4DF2-A6C5-9644F34D66BCQ30360726-D6F6ECD4-15AE-4178-BB35-FCE43B7AD719Q30863509-ACF6538C-2640-41ED-B138-3F97BD226B02Q31063042-24D27854-0281-459F-893E-09B12FE1BF58Q33247785-E3FD29B9-39FE-4938-94C4-A746201E9860Q33301317-E2A27C3F-D05C-4135-BC12-A2E4362A3D58Q33303921-3C7F429E-4D2F-4E95-9133-5417900761F1Q33334644-CFD64ABC-E8DC-4B77-8249-D2B29109B490Q33354570-7E6ADA2A-2AE0-4D37-B819-8B2B4BB03D72Q33377055-EC2CEA50-664C-48CB-9420-2DE1BE6DF6D9Q33477971-375B3F7E-D2E8-4478-B413-6BCF802D43DEQ33497330-91E65B88-7E31-49D1-B046-B9E67E1E1DC5Q33516016-3AFBA09C-489F-4204-BC27-06E9BF6B5898Q33518054-4127CF77-2728-457F-8FFF-D0F3CEAD8966Q33527440-6B26EC50-850C-49BF-9ED0-26CC07D287DFQ33648836-830BB907-E2C0-4C8B-B078-B420F61A1971Q33680325-DC74FF34-C5BD-4F41-AF8E-03AF9F8B7059Q33690691-A0C325DE-7F6F-4FA6-A6B0-4723110CEC54Q33732170-3A14214F-1D41-4772-8CFF-B003F777BD4EQ33739774-95590330-8A97-4B10-9BC6-49FBAF38BB3FQ33790058-EC524B49-0C5E-4848-96F5-34CE8772F110Q33866395-DD66CDF1-E69F-46A0-A307-5F8C20AEDB08Q33875831-77C5A433-8C01-4F0F-9DB3-FFBB756B1CD7Q33909191-095C41C1-CE23-4669-BBD9-6ECD0D162D80Q34029989-4DD2425E-5FC8-4393-9E33-53840E97B148Q34030031-3D03CA6E-3BDF-4278-B495-32089D453929Q34066281-3F8C727C-6E3C-4A0B-B677-02AE8A56F026Q34341865-77B70A74-3F54-46FB-9227-BE28E3ED4B7FQ34351266-E687BCDE-6549-4E19-96B7-754366FD9CCAQ34369813-953CA9CD-D6B7-449F-95F5-CA930D907313Q34386405-1FC51D3C-24C5-4D75-96CA-116B15463851Q34399197-69180740-124D-44A9-8119-C53EF0B2E3C8Q34419185-574850A5-6327-4456-AD38-DA54D8DE394FQ34450737-C200A539-3EDE-4923-8C6E-9D016154DFCBQ34492614-B0D2F37D-9E15-4E9C-A802-4463733F4773Q34565300-16B78B4B-CF87-4458-A107-70388E62FE71Q34994271-3165DB42-6910-427B-B7BB-06EB17F648C8Q35053652-EAC1C6B6-F968-4A19-B076-B9E22084022EQ35068722-BD034EE3-5CDB-47FB-9C55-67BF0AFB0673Q35073315-4949D4E1-66FD-4B1C-AB4A-00FD4AC9A0C4
P2860
A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A meta-analysis of the effect ...... erculin skin test measurements
@ast
A meta-analysis of the effect ...... erculin skin test measurements
@en
type
label
A meta-analysis of the effect ...... erculin skin test measurements
@ast
A meta-analysis of the effect ...... erculin skin test measurements
@en
prefLabel
A meta-analysis of the effect ...... erculin skin test measurements
@ast
A meta-analysis of the effect ...... erculin skin test measurements
@en
P2093
P2860
P356
P1433
P1476
A meta-analysis of the effect ...... erculin skin test measurements
@en
P2093
P2860
P304
P356
10.1136/THORAX.57.9.804
P407
P577
2002-09-01T00:00:00Z